Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019621 (
Langerhans cell histiocytosis
)
3,250
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immunohistochemical study on 26 cases of
Langerhans cell histiocytosis
(
LCH
) using several leukocyte antibodies in addition to traditionally used markers (S-100 protein and peanut agglutinin) revealed that the proliferating cells of
LCH
expressed UCHL1,
MT1
as well as classically known positivity for S-100 protein, HLA-DR and peanut agglutinin but were negative for OPD4. In comparison to S-100 protein peanut agglutinin (PNA) using a two stage method produced weaker staining and positively stained cells were sparse. Also in this study, a small proportion of proliferating cells in
LCH
was observed to be reactive for both myeloid/macrophage antigens (KPI, MAC 387 and lysozyme) and Langerhans cell marker (S-100 protein), verifying the existence of a hybrid form of histiocytes.
...
PMID:Immunohistochemical study on antigenic phenotype of Langerhans cell histiocytosis. 128 18
Langerhans cells and their pathologic counterparts can be identified in paraffin sections using immunohistochemical staining for S-100 protein. This procedure is useful in confirming a diagnosis of
Langerhans cell histiocytosis
(
LCH
). However, many other cell types are also positive for S-100 protein. Positive staining for CD1 (Leu 6) supports a diagnosis of
LCH
, but requires frozen tissue. A panel of antibodies would be desirable in confirming a diagnosis of
LCH
, particularly if these antibodies could be used on paraffin-embedded material. We studied the pattern of staining for commercially available monoclonal antibodies
MT1
, MT2, MB2, and LN1, which were originally marketed as lymphocyte markers, using paraffin-embedded tissue sections of cases of
LCH
. In all 20 cases pathologic Langerhans cells stained positively with
MT1
only. Various other S-100 protein-positive lesions were also examined with
MT1
and were consistently negative for
MT1
. Other cutaneous histiocytic and mast cell lesions were positive with
MT1
, but S-100 protein negative. Our results demonstrate that the monoclonal antibody
MT1
serves as an additional marker for
LCH
and, together with S-100 protein, would make up a diagnostic panel of antibodies for
LCH
to be used on routine paraffin-embedded sections.
...
PMID:Monoclonal antibody MT1: a marker for Langerhans cell histiocytosis. 219 Jan 98
The case of a boy aged 4 yrs and 7 months, with isolated pulmonary involvement by
Langerhans' cell histiocytosis
is reported. The presentation of the disease was a sudden pneumothorax, with no previous signs of respiratory disease. The case was confirmed by S-100 and
MT1
antibody staining, and was treated with pulse steroids and several pleural drainages, until the boy died after a large bilateral pneumothorax.
...
PMID:Sole pulmonary involvement by Langerhans' cell histiocytosis in a child. 822 40